Search
Now showing items 1-10 of 35
mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies
Greiner, J et al. (2004)
Wissenschaftlicher Artikel
Transient genetic labeling of human CD34-positive hematopoietic stem cells using nucleofection
Greiner, J et al. (2004)
Wissenschaftlicher Artikel
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
Greiner, Jochen et al. (2010)
Wissenschaftlicher Artikel
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia
Grenier, J et al. (2002)
Wissenschaftlicher Artikel
Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia
Greiner, Jochen et al. (2012)
Wissenschaftlicher Artikel
Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1(mut))
Greiner, Jochen et al. (2013)
Wissenschaftlicher Artikel
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation
Zenz, T et al. (2006)
Wissenschaftlicher Artikel
Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: A comparative study
Yao, Junxia et al. (2008)
Wissenschaftlicher Artikel
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses
Schmitt, Michael et al. (2008)
Wissenschaftlicher Artikel
Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition
Greiner, Jochen et al. (2020)
Wissenschaftlicher Artikel